Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Amortizatization of Intangibles: 2015-2025

Historic Amortizatization of Intangibles for Theravance Biopharma (TBPH) over the last 7 years, with Sep 2025 value amounting to $1.0 million.

  • Theravance Biopharma's Amortizatization of Intangibles fell 11.25% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 17.29%. This contributed to the annual value of $4.4 million for FY2024, which is 6.31% up from last year.
  • According to the latest figures from Q3 2025, Theravance Biopharma's Amortizatization of Intangibles is $1.0 million, which was up 6.60% from $940,000 recorded in Q2 2025.
  • Theravance Biopharma's Amortizatization of Intangibles' 5-year high stood at $1.7 million during Q4 2022, with a 5-year trough of $341,000 in Q1 2022.
  • Over the past 3 years, Theravance Biopharma's median Amortizatization of Intangibles value was $1.0 million (recorded in 2023), while the average stood at $1.0 million.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first crashed by 54.10% in 2022, then soared by 202.35% in 2023.
  • Over the past 5 years, Theravance Biopharma's Amortizatization of Intangibles (Quarterly) stood at $1.0 million in 2021, then skyrocketed by 65.86% to $1.7 million in 2022, then dropped by 16.25% to $1.4 million in 2023, then decreased by 26.26% to $1.1 million in 2024, then decreased by 11.25% to $1.0 million in 2025.
  • Its Amortizatization of Intangibles was $1.0 million in Q3 2025, compared to $940,000 in Q2 2025 and $966,000 in Q1 2025.